Serial Number | 86480624 |
Word Mark | HAMPLATIN |
Filing Date | Monday, December 15, 2014 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, October 13, 2023 |
Registration Number | 5171990 |
Registration Date | Tuesday, March 28, 2017 |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, June 7, 2016 |
Description of Mark | The mark consists of the term "HAMPLATIN" in stylized font. |
Goods and Services | Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Technical research and development in the fields of vaccines, medicines, dietary supplements and food; Technical Project studies in the nature of scientific research; Quality testing for medicines, dietary supplements, food and medicine intermediate; Chemical analysis; Chemical engineering; Working on and evaluation of chemical syntheses; Chemical research; Bacteriological research; Biological research; Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Industrial design |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, October 13, 2023 |
Primary Code | 005 |
First Use Anywhere Date | Tuesday, May 10, 2016 |
First Use In Commerce Date | Tuesday, May 10, 2016 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, October 13, 2023 |
Primary Code | 042 |
First Use Anywhere Date | Tuesday, May 10, 2016 |
First Use In Commerce Date | Tuesday, May 10, 2016 |
Party Name | MedOC Pharmaceutical Co., Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Changsha, Hunan CN |
Party Name | MedOC Pharmaceutical Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Changsha, Hunan CN |
Party Name | MedOC Pharmaceutical Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Changsha, Hunan CN |
Event Date | Event Description |
Friday, October 13, 2023 | CANCELLED SEC. 8 (6-YR) |
Monday, March 28, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Tuesday, March 28, 2017 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, February 22, 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Tuesday, February 21, 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Wednesday, February 15, 2017 | STATEMENT OF USE PROCESSING COMPLETE |
Wednesday, January 25, 2017 | USE AMENDMENT FILED |
Saturday, February 11, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, January 25, 2017 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, August 2, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, June 7, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 7, 2016 | PUBLISHED FOR OPPOSITION |
Wednesday, May 18, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, April 29, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, April 26, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, April 25, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, April 25, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, October 27, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, October 27, 2015 | NON-FINAL ACTION E-MAILED |
Tuesday, October 27, 2015 | NON-FINAL ACTION WRITTEN |
Tuesday, September 29, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, September 28, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, September 28, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, March 28, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, March 28, 2015 | NON-FINAL ACTION E-MAILED |
Saturday, March 28, 2015 | NON-FINAL ACTION WRITTEN |
Thursday, March 26, 2015 | ASSIGNED TO EXAMINER |
Wednesday, March 4, 2015 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, December 19, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, December 18, 2014 | NEW APPLICATION ENTERED |